Skip to main content
Fig. 2 | Journal of Neuroinflammation

Fig. 2

From: Brain injury, endothelial injury and inflammatory markers are elevated and express sex-specific alterations after COVID-19

Fig. 2

Differences across severity and clinical outcomes. Differences across severity and clinical outcomes. A Difference in SICAM1, sCD40L and IL1RA across controls, mild, moderate and severe COVID groups. B Difference in CC levels across functional outcomes at discharge. EOTAXIN, MDC and MIP1b were significantly different across the good and the poor functional outcome groups. However, when adjusted for age and sex, only MIP1b was independently associated with outcomes

Back to article page

Journal of Neuroinflammation

ISSN: 1742-2094